|
Part 1: Chemical
Product and Company Identification
SUBSTANCE: NITROUS OXIDE
TRADE NAMES/SYNONYMS: DINITROGEN
MONOXIDE; FACTITIOUS AIR; LAUGHING GAS; HYPONITROUS ACID ANHYDRIDE; NITROGEN (I)
OXIDE; NITROGEN OXIDE; STCC 4904340; UN 1070; NITROGEN OXIDE (N2O); DINITROGEN
OXIDE; NITROUS OXIDE, COMPRESSED; N2O; RTECS QX1350000
CHEMICAL FAMILY: inorganic, gas
COMPANY: PT ANEKA GAS INDUSTRI
Wisma 77 Lt.6 Jl. S. Parman Kav.77,
Jakarta Barat 11410
PHONE: 62-21 53670071
Creation date: 12 December 2005
Part 2:
Composition, Information on ingredients
COMPONENT: NITROUS OXIDE CAS NUMBER:
10024-97-2 EC NUMBER (EINECS): 233-032-0 PERCENTAGE: 100.0
Part 3: Hazards
Identifications
NFPA RATINGS (SCALE 0-4): HEALTH=1
FIRE=0 REACTIVITY=0 EMERGENCY OVERVIEW: PHYSICAL DESCRIPTION: Colorless gas or
liquid with a slightly sweet odor and taste. MAJOR HEALTH HAZARDS: potentially
fatal if inhaled, central nervous system depression, difficulty breathing
PHYSICAL HAZARDS: Containers may rupture or explode if exposed to heat.
POTENTIAL HEALTH EFFECTS: INHALATION: SHORT TERM EXPOSURE: nausea, vomiting,
symptoms of drunkenness, hyperactivity or drowsiness, hearing loss, suffocation,
death LONG TERM EXPOSURE: tingling sensation, impotence, reproductive effects
SKIN CONTACT: SHORT TERM EXPOSURE: blisters, frostbite LONG TERM EXPOSURE: no
information is available EYE CONTACT: SHORT TERM EXPOSURE: frostbite, blurred
vision LONG TERM EXPOSURE: no information is available INGESTION: SHORT TERM
EXPOSURE: frostbite LONG TERM EXPOSURE: no information is available CARCINOGEN
STATUS: OSHA: No NTP: No IARC: No
Part 4: First Aid
Measures
INHALATION: If adverse effects
occur, remove to uncontaminated area. Give artificial respiration if not
breathing. If breathing is difficult, oxygen should be administered by qualified
personnel. Get immediate medical attention. SKIN CONTACT: If frostbite or
freezing occur, immediately flush with plenty of lukewarm water (105-115 F;
41-46 C). DO NOT USE HOT WATER. If warm water is not available, gently wrap
affected parts in blankets. Get immediate medical attention. EYE CONTACT: Flush
eyes with plenty of water. INGESTION: If a large amount is swallowed, get
medical attention. NOTE TO PHYSICIAN: For inhalation, consider oxygen
Part 5: Fire
Fighting Measures
FIRE AND EXPLOSION HAZARDS:
Negligible fire hazard. Containers may rupture or explode if exposed to heat.
Gas/air mixtures are explosive. EXTINGUISHING MEDIA: carbon dioxide, regular dry
chemical Large fires: Use regular foam or flood with fine water spray. FIRE
FIGHTING: Move container from fire area if it can be done without risk. Cool
containers with water spray until well after the fire is out. Stay away from the
ends of tanks. For fires in cargo or storage area: Cool containers with water
from unmanned hose holder or monitor nozzles until well after fire is out. If
this is impossible then take the following precautions: Keep unnecessary people
away, isolate hazard area and deny entry. Let the fire burn. Use extinguishing
agents appropriate for surrounding fire. Cool containers with water spray until
well after the fire is out. Apply water from a protected location or from a safe
distance. Do not get water directly on material. Reduce vapors with water spray.
Avoid inhalation of material or combustion by-products. Stay upwind and keep out
of low areas. Consider downwind evacuation if material is leaking.
Part 6: Accidental
Release Measures
OCCUPATIONAL RELEASE: Stop leak if
possible without personal risk. Avoid contact with combustible materials. Keep
unnecessary people away, isolate hazard area and deny entry. Ventilate closed
spaces before entering.
Part 7: Handling
and Storage
STORAGE: Cylinder temperature should
not exceed 125 F (52 C). 29 CFR Subpart "H"-Hazardous Materials. National Fire
Protection Association publication #55, "Standard for the Storage, Use and
Handling of Compressed and Liquified Gases in Portable Cylinders". Compressed
Gas Association publication P-1, "Safe Handling of Compressed Gases in
Containers". Store and handle in accordance with current regulations and
standards: OSHA 29 CFR 1910.101
Part 8: Exposure
Controls, Personal Protection
EXPOSURE LIMITS: NITROUS OXIDE: 50
ppm ACGIH TWA 25 ppm (46 mg/m3) NIOSH recommended TWA (halogenated anesthetic
gas) 180 mg/m3 (100 ml/m3) DFG MAK (peak limitation category-II, 1) 100 ppm (183
mg/m3) UK OES TWA MEASUREMENT METHOD: Gas collection bag; Infrared spectrometry;
NIOSH IV # 6600 VENTILATION: Provide local exhaust ventilation system. Ensure
compliance with applicable exposure limits. EYE PROTECTION: For the gas: Eye
protection not required, but recommended. For the liquid: Wear splash resistant
safety goggles. Contact lenses should not be worn. Provide an emergency eye wash
fountain and quick drench shower in the immediate work area. CLOTHING: For the
gas: Protective clothing is not required. For the liquid: Wear appropriate
protective, cold insulating clothing. GLOVES: Wear insulated gloves. RESPIRATOR:
Under conditions of frequent use or heavy exposure, respiratory protection may
be needed. Respiratory protection is ranked in order from minimum to maximum.
Consider warning properties before use. Any supplied-air respirator with a full
facepiece that is operated in a pressure-demand or other positive-pressure mode.
Any self-contained breathing apparatus that has a full facepiece and is operated
in a pressure-demand or other positive-pressure mode. For Unknown Concentrations
or Immediately Dangerous to Life or Health - Any supplied-air respirator with
full facepiece and operated in a pressure-demand or other positive-pressure mode
in combination with a separate escape supply. Any self-contained breathing
apparatus with a full facepiece.
Part 9: Physical
and Chemical Properties
PHYSICAL DESCRIPTION: Colorless gas
or liquid with a slightly sweet odor and taste. MOLECULAR WEIGHT: 44.01
MOLECULAR FORMULA: N2-O BOILING POINT: -128 F (-89 C) FREEZING POINT: -132 F
(-91 C) VAPOR PRESSURE: 760 mmHg @ -88 C VAPOR DENSITY (air=1): 1.530 SPECIFIC
GRAVITY: Not applicable DENSITY: 1.8122 g/L @ 25 C WATER SOLUBILITY: 59% @ 25 C
PH: Not applicable VOLATILITY: Not applicable ODOR THRESHOLD: Not available
EVAPORATION RATE: Not applicable VISCOSITY: 0.0145 cP @ 25 C COEFFICIENT OF
WATER/OIL DISTRIBUTION: Not applicable SOLVENT SOLUBILITY: Soluble: sulfuric
acid, alcohol, alkali solutions, ether, oils
Part 10: Stability
and Reactivity
REACTIVITY: Stable at normal
temperatures and pressure. CONDITIONS TO AVOID: Avoid contact with combustible
materials. Protect from physical damage and heat. Containers may rupture or
explode if exposed to heat. INCOMPATIBILITIES: combustible materials, metals,
bases, reducing agents, peroxides, metal salts, metal oxides NITROUS OXIDE:
ACETYLENE: Forms explosive mixture. ALUMINUM: Oxidizes. AMMONIA: Forms explosive
mixture. BORON (AMORPHOUS): Ignites when heated. CADMIUM: Oxidizes @ 300 C.
CARBON MONOXIDE: Explosion hazard. COBALT: Oxidizes @ 200 C. COPPER: Oxidizes @
150 C. DITUNGSTEN CARBIDE: Incandescent reaction. ETHANOL: Mixtures with
supercritical nitrous oxide may detonate. HYDRAZINE: Ignites. HYDROGEN: Forms
explosive mixture. HYDROGEN + OXYGEN: Ignition reaction with possible explosion.
HYDROGEN SULFIDE: Forms explosive mixture. IRON: Oxidizes @ 170 C. LEAD:
Oxidizes @ 300 C. LITHIUM HYDRIDE: Ignites. METHANOL: Mixtures with
supercritical nitrous oxide may detonate. NICKEL: Oxidizes @ 200 C. OXIDIZABLE
ORGANIC MATERIALS: Mixtures with supercritical nitrous oxide may detonate.
ORGANIC PEROXIDES: Incompatable. PHENYLLITHIUM: Forms unstable products.
PHOSPHINE: Explodes when sparked. REDUCING AGENTS (STRONG): Violent reaction @
room temperature. SODIUM (GASEOUS): Incandesces @ 260 C. STANNOUS CHLORIDE:
Violent reaction. TIN (II) OXIDE: Ignites @ 400 C. TUNGSTEN CARBIDE: Ignites
with incandescence @ 600 C. HAZARDOUS DECOMPOSITION: Thermal decomposition
products: oxides of nitrogen POLYMERIZATION: Will not polymerize.
Part 11:
Toxicological Information
NITROUS OXIDE: TOXICITY DATA: 24
mg/kg/2 hour(s) inhalation-human TCLo; 50 ppm/6 hour(s)-13 week(s) intermittent
inhalation-mouse TCLo CARCINOGEN STATUS: IARC: Human Inadequate Evidence, Animal
Inadequate Evidence, Group 3 (Anesthetics, volatile); ACGIH: A4 -Not
Classifiable as a Human Carcinogen TARGET ORGANS: central nervous system
MUTAGENIC DATA: sex chromosone loss and non disjunction - Drosophila
melanogaster inhalation 99 pph 6 minute(s)-continuous; DNA inhibition - human
inhalation 50 pph 24 hour(s); DNA inhibition - rat inhalation 75000 ppm 24
hour(s); other mutation test systems - rat inhalation 50 pph 24 hour(s)
REPRODUCTIVE EFFECTS DATA: 5 pph inhalation-rat TCLo/4 hour(s) 6-15 day(s)
pregnant female continuous; 20 pph inhalation-rat TCLo/8 hour(s) 28 day(s) male;
50 pph inhalation-rat TCLo/24 hour(s) 8-11 day(s) pregnant female continuous; 50
ppm inhalation-rat TCLo/6 hour(s) 30 day(s) male; 1 pph inhalation-rat TCLo/8
hour(s) 1-21 day(s) pregnant female continuous; 50 pph inhalation-rat TCLo/4
hour(s) 14 day(s) pregnant female continuous; 3 gm/kg subcutaneous-rat TDLo 8
day(s) pregnant female continuous; 3 gm/kg subcutaneous-rat TDLo 8 day(s)
pregnant female continuous; 75 pph inhalation-mouse TCLo/6 hour(s) 14 day(s)
pregnant female continuous; 5000 ppm inhalation-mouse TCLo/4 hour(s) 14 day(s)
pregnant female continuous; 90 pph inhalation-hamster TCLo/24 hour(s) 10 day(s)
pregnant female continuous; 95 pph inhalation-hamster TCLo/24 7 day(s) pregnant
female continuous ADDITIONAL DATA: Central nervous system depressants may
enhance the toxic effects. HEALTH EFFECTS: INHALATION: ACUTE EXPOSURE: NITROUS
OXIDE: Inhalation of high concentrations without adequate oxygen can result in
headache and serious anoxia causing fatal cardiac arrhythmias or brain damage
with cerebral edema, permanent mental deficit, and visual system involvement.
High concentrations mixed with air or oxygen may produce signs of central
nervous system depression including drowsiness, lightheadedness, confusion,
hysteria, anesthesia, and unconsciousness. Some persons may experience nausea,
and occasionally vomiting, following anesthesia. Anesthetic concentrations may
produce permanent hearing loss in persons who have had middle ear surgery.
Exposure of pregnant rats to 75% nitrous oxide for 8 hours on the 15th day of
gestation resulted in permanent alterations in neurobehavioral output of the
newborns as exhibited by hyperactivity in males and hypoactivity in females.
CHRONIC EXPOSURE: NITROUS OXIDE: Prolonged occupational exposure or abuse has
resulted in neurologic effects including initial signs of numbness, paresthesias,
and loss of pain and temperature sensation, progressing to muscle weakness, loss
of balance, gait ataxia, Lhermitte's sign, impotence, sphincter difficulties,
loss of bladder and vaginal sensation, and reduction in dexterity, cognition,
and motor and audiovisual skills. Recovery may occur in months, but damage may
be permanent. Signs of bone marrow depression including fatal aplastic anemia
have been reported. There have also been increased incidences of kidney and
liver disorders, spontaneous abortions, and fetal malformations reported among
dentists and their assistants. Exposure to nitrous oxide in utero prior to
organogenesis resulted in physical malformations in rat fetuses; permanent
alterations in brain function can result following exposure during a period
beyond major organogenesis. Prolonged exposure produced some damage to
chromosomes in bone marrow cells and spermatogonial cells in male rats. 500 ppm
8 hrs/day/35 days disrupted hormonal cycles and decreased conception in female
rats. SKIN CONTACT: ACUTE EXPOSURE: NITROUS OXIDE: No adverse effects have been
reported from the gas. Due to rapid evaporation, the liquid may cause frostbite
with redness, tingling, and pain or numbness. In more severe cases, the skin may
become hard and white and blisters may form. CHRONIC EXPOSURE: NITROUS OXIDE: No
data available. EYE CONTACT: ACUTE EXPOSURE: NITROUS OXIDE: No adverse effects
have been reported from the gas. Due to rapid evaporation, the liquid may cause
frostbite with redness, pain, and blurred vision. CHRONIC EXPOSURE: NITROUS
OXIDE: No data available. INGESTION: ACUTE EXPOSURE: NITROUS OXIDE: If the
liquid is swallowed, frostbite damage of the lips, mouth, and mucous membranes
may occur. CHRONIC EXPOSURE: NITROUS OXIDE: No data available
Part 12:
Ecological Information
Not available
Part 13: Disposal
Consideration
Dispose in accordance with all
applicable regulations. Part 14: Transport Information U.S. DOT 49 CFR 172.101:
PROPER SHIPPING NAME: Nitrous oxide ID NUMBER: UN1070 HAZARD CLASS OR DIVISION:
2.2 LABELING REQUIREMENTS: Nonflammable gas; Oxidizer PACKAGING AUTHORIZATIONS:
EXCEPTIONS: 49 CFR 173.306 NON-BULK PACKAGING: 49 CFR 173.304 BULK PACKAGING: 49
CFR 173.314, 315 QUANTITY LIMITATIONS: PASSENGER AIRCRAFT OR RAILCAR: 75 kg
CARGO AIRCRAFT ONLY: 150 kg LAND TRANSPORT ADR/RID: SUBSTANCE NAME: Nitrous
oxide (N2O)/Nitrous oxide UN NUMBER: UN1070 ADR/RID CLASS: 2 ITEM NUMBER:
5(a)/2O WARNING SIGN/LABEL: 2; 05/2; 05; 13 HAZARD ID NUMBER: 25 AIR TRANSPORT
IATA/ICAO: PROPER SHIPPING NAME: Nitrous oxide, compressed UN/ID NUMBER: UN1070
IATA/ICAO CLASS: 2.2 SUBSIDIARY RISK: 5.1 LABEL: Nonflammable gas; Oxidizer
MARITIME TRANSPORT IMDG: CORRECT TECHNICAL NAME: Nitrous oxide UN/ID NUMBER:
UN1070 IMDG CLASS: 2(2.2) SUBSIDIARY RISK LABEL: Oxidizing agent EmS No.: 2-08
MFAG Table No.: none IMDG CODE PAGE: 2166
WE BELIEVE THE INFORMATION SOURCE IS
RELIABLE AND THE INFORMATION IS ACCURATE AS OF THE DATE HEREOF, HOWEVER,
ACCURACY OR COMPLETENESS IS NOT GUARANTEED AND NO WARRANTY OF ANY TYPE IS
GRANTED.
Back to top |